The Miami Entrepreneur

Drugmaker Novartis climbs 4.4% after guidance rise on sales of blockbuster drugs

Read Time:9 Second

Shares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance following better-than-expected first-quarter results.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post Directors Fortnight Documentary ‘The Falling Sky’ Sets World Sales With Rediance (EXCLUSIVE)
Next post Apple iPhone sales tumbled in China in first quarter, research firm says